Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder – a longitudinal structural magnetic resonance imaging study
Open Access
- 5 September 2024
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-9
Abstract
Opioid use disorder (OUD) has been linked to macroscopic structural alterations in the brain. The monthly injectable, extended-release formulation of μ-opioid antagonist naltrexone (XR-NTX) is highly effective in reducing opioid craving and preventing opioid relapse. Here, we investigated the neuroanatomical effects of XR-NTX by examining changes in cortical thickness during treatment for OUD. Forty-seven OUD patients underwent structural magnetic resonance imaging and subjectively rated their opioid craving ≤1 day before (pre-treatment) and 11 ± 3 days after (on-treatment) the first XR-NTX injection. A sample of fifty-six non-OUD individuals completed a single imaging session and served as the comparison group. A publicly available [¹¹C]carfentanil positron emission tomography dataset was used to assess the relationship between changes in cortical thickness and μ-opioid receptor (MOR) binding potential across brain regions. We found that the thickness of the medial prefrontal and anterior cingulate cortices (mPFC/aCC; regions with high MOR binding potential) was comparable between the non-OUD individuals and the OUD patients at pre-treatment. However, among the OUD patients, mPFC/aCC thickness significantly decreased from pre-treatment to on-treatment. A greater reduction in mPFC/aCC thickness was associated with a greater reduction in opioid craving. Taken together, our study suggests XR-NTX-induced cortical thickness reduction in the mPFC/aCC regions in OUD patients. The reduction in thickness does not appear to indicate a restoration to the non-OUD level but rather reflects XR-NTX’s distinct therapeutic impact on an MOR-rich brain structure. Our findings highlight the neuroplastic effects of XR-NTX that may inform the development of novel OUD interventions.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K01DA051709, T32DA028874, R01DA036028)
- Brain and Behavior Research Foundation (NARSAD #30780)
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
- U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R00AA026892)
This publication has 108 references indexed in Scilit:
- Mu-opioid receptors modulate the stability of dendritic spinesProceedings of the National Academy of Sciences, 2005
- Neural Correlates of Behavioral Preference for Culturally Familiar DrinksNeuron, 2004
- A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRINeuroImage, 2003
- Impulse control differences between abstinent heroin users and matched controlsBrain Injury, 2002
- The neural basis of romantic loveNeuroReport, 2000
- Measuring the thickness of the human cerebral cortex from magnetic resonance imagesProceedings of the National Academy of Sciences, 2000
- Impulsive and self-control choices in opioid-dependent patients and non-drug-using control patients: Drug and monetary rewards.Experimental and Clinical Psychopharmacology, 1997
- Perinatal opiate treatment delays growth of cortical dendritesNeuroscience Letters, 1990
- Endogenous opioid systems and the regulation of dendritic growth and spine formationJournal of Comparative Neurology, 1989
- Neuropsychological performance in opiate addicts after rapid detoxificationDrug and Alcohol Dependence, 1987